BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29394905)

  • 1. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease.
    Chinnery F; Bashevoy G; Blatch-Jones A; Douet L; Puddicombe S; Raftery J
    Trials; 2018 Feb; 19(1):87. PubMed ID: 29394905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.
    Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S
    Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden.
    Hagstrom EL; Patel S; Karimkhani C; Boyers LN; Williams HC; Hay RJ; Weinstock MA; Armstrong AW; Dunnick CA; Margolis DJ; Dellavalle RP
    J Am Acad Dermatol; 2015 Sep; 73(3):383-91.e1. PubMed ID: 26051697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
    Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
    BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the international use of health technology assessments: exploring the merits of different methods when applied to the National Institute of Health Research Health Technology Assessment (NIHR HTA) programme.
    Wright D; Milne R; Price A; Tose N
    Int J Technol Assess Health Care; 2013 Apr; 29(2):192-7. PubMed ID: 23552058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical relevance and newsworthiness of NIHR HTA-funded research: a cohort study.
    Wright D; Young A; Iserman E; Maeso R; Turner S; Haynes RB; Milne R
    BMJ Open; 2014 May; 4(5):e004556. PubMed ID: 24812191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities Among Gastrointestinal Disorders in Research Funding From the National Institutes of Health.
    Clerx E; Kupfer SS; Leffler DA;
    Gastroenterology; 2017 Oct; 153(4):877-880. PubMed ID: 28867278
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme.
    Raftery J; Young A; Stanton L; Milne R; Cook A; Turner D; Davidson P
    Health Technol Assess; 2015 Feb; 19(11):1-138. PubMed ID: 25671821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matching taxpayer funding to population health needs: not so simple.
    Lauer MS; Gordon D; Olive M
    Circ Res; 2015 Apr; 116(8):1301-3. PubMed ID: 25858063
    [No Abstract]   [Full Text] [Related]  

  • 10. Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme.
    Raftery J; Hanney S; Greenhalgh T; Glover M; Blatch-Jones A
    Health Technol Assess; 2016 Oct; 20(76):1-254. PubMed ID: 27767013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of NIHR HTA Programme funded research on NICE clinical guidelines: a retrospective cohort.
    Turner S; Bhurke S; Cook A
    Health Res Policy Syst; 2015 Aug; 13():37. PubMed ID: 26297470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of disease, research funding and innovation in the UK: Do new health technologies reflect research inputs and need?
    Ward D; Martino O; Packer C; Simpson S; Stevens A
    J Health Serv Res Policy; 2013 Apr; 18(1 Suppl):7-13. PubMed ID: 27552774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging the gap between methods research and the needs of policy makers: a review of the research priorities of the National Institute for Health and Clinical Excellence.
    Longworth L; Sculpher MJ; Bojke L; Tosh JC
    Int J Technol Assess Health Care; 2011 Apr; 27(2):180-7. PubMed ID: 21447260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping public health research across the National Institute for Health Research 2006-2013.
    Guegan EW; Dorling H; Ollerhead L; Westmore M
    BMC Public Health; 2016 Aug; 16(1):911. PubMed ID: 27581493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
    Head MG; Brown RJ; Clarke SC
    J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matching taxpayer funding to population health needs.
    Hanna M
    Circ Res; 2015 Apr; 116(8):1296-300. PubMed ID: 25858062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To what extent is health and medical research funding associated with the burden of disease in Australia?
    Aoun S; Pennebaker D; Pascal R
    Aust N Z J Public Health; 2004 Feb; 28(1):80-6. PubMed ID: 15108752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between disease burden and research funding through the Health Research Foundation in Spain].
    Gómez-García T; Moreno-Casbas T; González-María E; Fuentelsaz-Gallego C
    Enferm Clin; 2014; 24(4):219-32. PubMed ID: 24819151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the impact of the NHS Health Technology Assessment Programme.
    Hanney S; Buxton M; Green C; Coulson D; Raftery J
    Health Technol Assess; 2007 Dec; 11(53):iii-iv, ix-xi, 1-180. PubMed ID: 18031652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation between funding by the National Institutes of Health and the burden of disease.
    Gross CP; Anderson GF; Powe NR
    N Engl J Med; 1999 Jun; 340(24):1881-7. PubMed ID: 10369852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.